Recommendations for the validation of flow cytometric testing during drug development: I instrumentation

Journal of Immunological Methods

Volumn 363, Issue 2, 2011, Pages 104-119

  Green, Cherie L ^a   Brown, Lynette ^b   Stewart, Jennifer J ^b   Xu, Yuanxin ^c   Litwin, Virginia ^d   Mc Closkey, Thomas W ^e  

^a AMGEN INC   (United States)

^b Flow Contract Site Laboratory   (United States)

^c GENZYME CORPORATION   (United States)

^d Laboratory Science   (United States)

^e ICON Central Laboratories   (United States)

Author keywords

Biomarker; Drug development; Flow cytometry; Instrument qualification; Instrument validation

Indexed keywords

ARTICLE; COMPUTER PROGRAM; FLOW CYTOMETRY; INSTRUMENT VALIDATION; INSTRUMENTATION; LABORATORY TEST; PRIORITY JOURNAL;

DRUG DISCOVERY; FLOW CYTOMETRY; REPRODUCIBILITY OF RESULTS; TRANSLATIONAL RESEARCH;

EID: 78650032734     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2010.07.004     Document Type: Article

References (40)

1. Bansal S.K., Layloff T., Bush E.D., Hamilton M., Hankinson E.A., Landy J.S., Lowes S., Nasr M.M., Jean P.A., Shah V.P. Qualification of analytical instruments for use in the pharmaceutical industry: a scientific approach. AAPS PharmSciTech. 2004, 5(1). (article 22).
2. Barlogie B., Latreille J., Freireich E.J., Fu C.T., Mellard D., Meistrich M., Andreeff M. Characterization of hematologic malignancies by flow cytometry. Blood Cells 1980, 6:719.
3. Barr I.G., Toh B.H. Routine flow cytometric diagnosis of lymphoproliferative disorders. Journal of Clinical Immunology 1983, 3:184.
4. Chadwick G.L. Clinical trials in the 21st century: a global approach. Research in Nursing & Health 2001, 24:541.
5. Chapman G.V. Instrumentation for flow cytometry. Journal of Immunological Methods 2000, 243:3.
6. Crissman H.A., Stevenson A.P., Orlicky D.J., Kissane R.J. Detailed studies on the application of three fluorescent antibiotics for DNA staining in flow cytometry. Stain Technology 1978, 53:321.
7. Darzynkiewicz Z., Traganos F., Sharpless T.K., Melamed M.R. Cell cycle-related changes in nuclear chromatin of stimulated lymphocytes as measured by flow cytometry. Cancer Research 1977, 37:4635.
8. Ezzelle J., Rodriguez-Chavez I.R., Darden J.M., Stirewalt M., Kunwar N., Hitchcock R., Walter T., D'Souza M.P. Guidelines on good clinical laboratory practice: bridging operations between research and clinical research laboratories. Journal of Pharmaceutical & Biomedical Analysis 2008, 46:18.
9. Fernandes G., Garrett T., Nair M., Straus D., Good R.A., Gupta S. Studies in acute leukemia. I. Antibody-dependent and spontaneous cellular cytotoxicity by leukemic blasts from patients with acute nonlymphoid leukemia. Blood 1979, 54:573.
10. Fox A. GLP regulations vs. ISO 17025 requirements: how do they differ?. Accreditation and Quality Assurance: Journal for Quality, Comparability and Reliability in Chemical Measurement 2003, 8(6):303.
11. Fulwyler M.J. Electronic separation of biological cells by volume. Science 1965, 150:910.
12. Giezen T.J., Mantel-Teeuwisse A.K., Leufkens H.G. Pharmacovigilance of biopharmaceuticals: challenges remain. Drug Safety 2009, 32:811.
13. Giorgi J.V., Fahey J.L., Smith D.C., Hultin L.E., Cheng H.L., Mitsuyasu R.T., Detels R. Early effects of HIV on CD4 lymphocytes in vivo. Journal of Immunology 1987, 138:3725.
14. Giorgi J.V., Cheng H.L., Margolick J.B., Bauer K.D., Ferbas J., Waxdal M., Schmid I., Hultin L.E., Jackson A.L., Park L. Quality control in the flow cytometric measurement of T-lymphocyte subsets: the multicenter AIDS cohort study experience. The Multicenter AIDS Cohort Study Group. Clinical Immunology & Immunopathology 1990, 55:173.
15. Herzenberg L.A., Sweet R.G., Herzenberg L.A. Fluorescence-activated cell sorting. Scientific American 1976, 234:108.
16. Hoffman R.A. Standardization, calibration, and control in flow cytometry. Current Protocols in Cytometry Chapter, 1 2005.
17. Hoffman R.A., Wood J.C. Characterization of Flow Cytometer Instrument Sensitivity. Current Protocols in Cytometry Chapter, 1 2007.
18. Hultin L.E., Menendez F.A., Hultin P.M., Jamieson B.D., O'Gorman M.R., Borowski L., Matud J.L., Denny T.N., Margolick J.B. Assessing immunophenotyping performance: proficiency-validation for adopting improved flow cytometry methods. Cytometry Part B, Clinical Cytometry 2007, 72:249.
19. Kamentsky L.A., Melamed M.R., Derman H. Spectrophotometer: new instrument for ultrarapid cell analysis. Science 1965, 150:630.
20. Krutzik P.O., Nolan G.P. Fluorescent cell barcoding in flow cytometry allows high-throughput drug screening and signaling profiling. Nature Methods 2006, 3:361.
21. Lappin P.B. Flow cytometry in preclinical drug development. Methods in Molecular Biology 2010, 598:303.
22. Levering W.H.B.M., Preijers F.W.M.B., van Wieringen W.N., Kraan J., van Beers W.A.M., Sintnicolaas K., van Rhenen D.J., Gratama J.W. Flow cytometric CD34+ stem cell enumeration: lessons from nine years' external quality assessment within the Benelux countries. Cytometry 2007, 72B(3):178.
23. Maecker H.T., Hassler J., Payne J.K., Summers A., Comatas K., Ghanayem M., Morse M.A., Clay T.M., Lyerly H.K., Bhatia S., Ghanekar S.A., Maino V.C., Delarosa C., Disis M.L. Precision and linearity targets for validation of an IFNgamma ELISPOT, cytokine flow cytometry, and tetramer assay using CMV peptides. BMC Immunol 2008, 9:9.
24. Maggon K. Monoclonal antibody "gold rush". Current Medicinal Chemistry 2007, 14(18):1978.
25. Owens M.A., Vall H.G., Hurley A.A., Wormsley S.B. Validation and quality control of immunophenotyping in clinical flow cytometry. Journal of Immunological Methods 2000, 243(1-2):33.
26. Paxton H., Kidd P., Landay A., Giorgi J., Flomenberg N., Walker E., Valentine F., Fahey J., Gelman R. Results of the flow cytometry actg quality control program analysis and findings. Clinical Immunology & Immunopathology 1989, 52(1):68.
27. Plaeger-Marshall S., Spina C.A., Giorgi J.V. Alterations in cytotoxic and phenotypic subsets of natural killer cells in acquired immune deficiency syndrome (AIDS). Journal of Clinical Immunology 1987, 7(1):16.
28. Prince H.E., John J.K. Early activation marker expression to detect impaired proliferative responses to pokeweed mitogen and tetanus toxoid studies in patients with aids and related disorders. Diagnostic Immunology 1986, 4(6):306.
29. Purvis N., Stelzer G. Multi-platform, multi-site instrumentation and reagent standardization. Cytometry 1998, 33:156.
30. Robinson J.P. High-content analysis - CHI's seventh annual conference - flow cytometry in drug discovery and development. Idrugs 2010, 13:153.
31. Sarzotti-Kelsoe M., Cox J., Cleland N., Denny T., Hural J., Needham L., Ozaki D., Rodriguez-Chavez I.R., Stevens G., Stiles T., Tarragona-Fiol T., Simkins A. Evaluation and recommendations on good clinical laboratory practice (GCLP) guidelines for phase I-III HIV vaccine clinical trials. Retrovirology 2009, 6:206.
32. Schwartz A., Gaigalas A.K., Wang L., Marti G.E., Vogt R.F., Fernandez-Repollet E. Formalization of the MESF unit of fluorescence intensity. Cytometry Part B, Clinical Cytometry 2004, 57:1.
33. Shults K.E., Miller D.T., Davis B.H., Flye L., Hobbs L.A., Stelzer G.T. A standardized ZAP-70 assay - lessons learned in the trenches. Cytometry Part B, Clinical Cytometry 2006, 70:276.
34. Sklar L.A., Carter M.B., Edwards B.S. Flow cytometry for drug discovery, receptor pharmacology and high-throughput screening. Current Opinion in Pharmacology 2007, 7:527.
35. Smith, P.J., Edward, R., Errington, R.J., 2010. Recent Advances in Flow Cytometry: Platforms, Tools and the Challenges for Data Analysis. In: Litwin, V., Marder, P. (Eds.), Flow Cytometry in Drug Discovery and Development. Wiley-Blackwell, John Wiley & Sons, Inc.
36. Twombly R. Leaders worry that US is losing edge on cancer clinical trials. Journal of the National Cancer Institute 2008, 100:1196.
37. Wang L., Abbasi F., Gaigalas A.K., Hoffman R.A., Flagler D., Marti G.E. Discrepancy in measuring CD4 expression on T-lymphocytes using fluorescein conjugates in comparison with unimolar CD4-phycoerythrin conjugates. Cytometry Part B, Clinical Cytometry 2007, 72:442.
38. Wang L., Gaigalas A.K., Marti G., Abbasi F., Hoffman R.A. Toward quantitative fluorescence measurements with multicolor flow cytometry. Cytometry Part A: The Journal of the International Society for Analytical Cytology 2008, 73:279.
39. Wormsley S.B., Collins M.L., Royston I. Comparative density of the human T-cell antigen T65 on normal peripheral blood T cells and chronic lymphocytic leukemia cells. Blood 1981, 57:657.
40. Zoog S.J., Itano A., Trueblood E., Pacheco E., Zhou L., Zhang X., Ferbas J., Ng G.Y., Juan G. Antagonists of CD117 (cKit) signaling inhibit mast cell accumulation in healing skin wounds. Cytometry Part A: The Journal of the International Society for Analytical Cytology 2009, 75:189.